Xylem Statistics

Total Valuation

Xylem has a market cap or net worth of GBP 22.42 billion. The enterprise value is 23.63 billion.

Market Cap	22.42B
Enterprise Value	23.63B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	Feb 18, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+11.62%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	241.45M

Valuation Ratios

The trailing PE ratio is 31.54.

PE Ratio	31.54
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	99.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.83, with an EV/FCF ratio of 31.41.

EV / Earnings	33.24
EV / Sales	3.57
EV / EBITDA	16.83
EV / EBIT	27.39
EV / FCF	31.41

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.22.

Current Ratio	1.75
Quick Ratio	1.19
Debt / Equity	0.22
Debt / EBITDA	1.34
Debt / FCF	2.59
Interest Coverage	25.48

Financial Efficiency

Return on equity (ROE) is 8.45% and return on invested capital (ROIC) is 5.34%.

Return on Equity (ROE)	8.45%
Return on Assets (ROA)	4.30%
Return on Invested Capital (ROIC)	5.34%
Return on Capital Employed (ROCE)	7.92%
Revenue Per Employee	297,351
Profits Per Employee	30,909
Employee Count	23,000
Asset Turnover	0.53
Inventory Turnover	5.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.93% in the last 52 weeks. The beta is 1.08, so Xylem's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-6.93%
50-Day Moving Average	125.53
200-Day Moving Average	128.82
Relative Strength Index (RSI)	35.75
Average Volume (20 Days)	374

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.04

Income Statement

In the last 12 months, Xylem had revenue of GBP 6.84 billion and earned 710.91 million in profits. Earnings per share was 2.92.

Revenue	6.84B
Gross Profit	2.57B
Operating Income	895.42M
Pretax Income	868.26M
Net Income	710.91M
EBITDA	1.34B
EBIT	895.42M
Earnings Per Share (EPS)	2.92

Full Income Statement

Balance Sheet

The company has 895.42 million in cash and 1.95 billion in debt, giving a net cash position of -1.06 billion.

Cash & Cash Equivalents	895.42M
Total Debt	1.95B
Net Cash	-1.06B
Net Cash Per Share	n/a
Equity (Book Value)	8.69B
Book Value Per Share	34.98
Working Capital	1.41B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.01 billion and capital expenditures -256.41 million, giving a free cash flow of 752.44 million.

Operating Cash Flow	1.01B
Capital Expenditures	-256.41M
Free Cash Flow	752.44M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 37.51%, with operating and profit margins of 13.09% and 10.39%.

Gross Margin	37.51%
Operating Margin	13.09%
Pretax Margin	12.70%
Profit Margin	10.39%
EBITDA Margin	19.66%
EBIT Margin	13.09%
FCF Margin	11.00%

Dividends & Yields

This stock pays an annual dividend of 1.16, which amounts to a dividend yield of 0.96%.

Dividend Per Share	1.16
Dividend Yield	0.96%
Dividend Growth (YoY)	7.84%
Years of Dividend Growth	7
Payout Ratio	39.33%
Buyback Yield	-11.62%
Shareholder Yield	-10.67%
Earnings Yield	3.17%
FCF Yield	3.36%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Xylem has an Altman Z-Score of 4.49.

Altman Z-Score	4.49
Piotroski F-Score	n/a